Asan Medical Center
Seoul, South Korea
Location status: Recruiting
Location contact
Jung-Hee Ham
CONTACT
Seung-Jung Park, MD,PhD
CONTACT
Seung-Jung Park, MD,PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT02039752
The purpose of this study is to evaluate long-term prognoses of patients with multivessel coronary disease treated medically or surgically or percutaneously in real world practice.
Interested in participating?
Request Info19 year and older
All sexes
Observational
Seoul, South Korea
Location status: Recruiting
Jung-Hee Ham
CONTACT
Seung-Jung Park, MD,PhD
CONTACT
Seung-Jung Park, MD,PhD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Medically, Surgically, Percutaneously
Time frame: 1year
death, myocardial infarction, stroke, revascularization
Time frame: 1year
Time frame: 1year
Time frame: 1year
Time frame: 1year
Time frame: 1year
Time frame: 1year
Time frame: 1year
Time frame: 1year
by ARC(Academic Research Consortium) category
Seung-Jung Park
Other
Asan Medical Center Registry for Multivessel
Acronym: ASAN MV
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07720349
Arterial Occlusive Diseases, Arteriosclerosis
Arendal, Norway
View Trial DetailsNCT02038127
Arterial Occlusive Diseases, Arteriosclerosis
Chuncheon, Gangwon-do, South Korea
View Trial DetailsNCT07190690
Arterial Occlusive Diseases, Arteriosclerosis
Alicante, Spain
View Trial DetailsNCT05611307
ASCVD, Arterial Occlusive Diseases
Indianapolis, Indiana, United States
View Trial Details